[REVISION HISTORY]
Dominican Republic launches High-Cost Medication Fund
Updated 4 times since CLSTR started tracking revisions of this situation.
What changed
2026-10-09 17:00 UTC → 2026-10-12 21:44 UTC ·
added
removed
Dominican Republic implements launches High-Cost Medication Fund
The High-Cost Medication Fund (FOMAC) has officially launched in the Dominican Republic, providing 100% coverage for essential medications without copayments. Approved by the National Council of Social Security (CNSS) in the Dominican Republic has approved the implementation of the High-Cost Medication Fund (FOMAC). Developed and presented by the Superintendency Ministry of Public Health and Labor Risks (SISALRIL), this specialized, capitalizable fund is integrated into SISALRIL, the Family Health Insurance (SFS) system to improve access through joint purchasing and economies of scale. fund targets approximately 6,400 affiliates in its initial phase. The CNSS has authorized 100% coverage for program covers 13 high-cost medications, targeting key drugs for 16 catastrophic diseases such as autoimmune diseases, acromegaly, spinal muscular atrophy, and including various cancers, including breast rheumatoid arthritis, psoriasis, and lung cancer. Under this system, patients are exempt spinal muscular atrophy. To ensure financial sustainability, the system utilizes centralized volume purchasing to generate savings, with funding drawn directly from copayments the Family Health Insurance (SFS) system without requiring additional contributions from workers or moderate fees for medications financed by FOMAC. employers. The initiative also expands pediatric cancer care to include specialized diagnostic tests, PET-CT studies, biopsies, implementation includes a transition and retina therapies. However, operational capitalization period of up to twelve months. Following the launch, the Dominican Society of Medical Oncology (SODOM) Rheumatology (SDR) has criticized called for the selection expansion of medications. SODOM President Dr. Miguel Monanci stated that the list includes molecules with ‘ridiculously low’ usage while excluding innovative therapies approved by the FDA and EMA that serve as the gold standard for patient survival. Monanci further argued that the decision lacked consultation with medical professionals fund to include a broader range of rheumatic and noted that systemic delays within immunomediated conditions. While acknowledging the Ministry inclusion of Public Health’s High-Cost Medication Program can result in patients waiting over a year six relevant medications for treatment. The society specifically highlighted that rheumatic diseases in the current selection does not adequately address breast cancer, the most prevalent cancer among Dominican women. To support the expansion of coverage, phase, the Social Security Treasury (TSS) announced a new per capita rate for additional dependents, including parents SDR emphasized that true benefit depends on access conditions, eligibility, and children over 21, which is scheduled to be reflected in October payments. continuous supply. The FOMAC has now officially launched, aiming to support approximately 6,400 affiliates society proposed adding coverage for conditions such as systemic lupus erythematosus, ankylosing sponditis, scleroderma, Sjögren's disease, high-risk osteoporosis, multiple sclerosis, and systemic vasculitis in its initial phase. The fund addresses complex pathologies where annual treatment costs can reach up to 16 million pesos. future stages.
Versions
- 2026-10-12 21:44 UTC Dominican Republic launches High-Cost Medication Fund
- 2026-10-09 17:00 UTC Dominican Republic implements High-Cost Medication Fund
- 2026-10-05 21:53 UTC Dominican Republic high-cost medication fund implementation
- 2026-10-04 20:42 UTC Dominican Republic high-cost medication fund implementation
- 2026-10-03 03:00 UTC Dominican Republic high-cost medication fund implementation
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.